← Back to patent-cliff list
CAS 406218-17-5
(4R)-4-Hydroxy-4-phenylbutanamide
Codes: (III)131699-11-a
Application context (from source-drug indications)
分离性焦虑R-fluoxetineAnxietyR-fluoxetineAnxiety disorderR-fluoxetine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| R-fluoxetine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-Benzoylpropanoic acid→(5R)-5-Phenyloxolan-2-one→(4R)-4-Hydroxy-4-phenylbutanamide→(6R)-6-Phenyl-1,3-oxazinan-2-one→1-Chloro-4-(trifluoromethyl)benzene→(3R)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrogen chloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.